Self-identification of nonpharmaceutical fentanyl exposure following heroin overdose.

Matthew K GriswoldPeter R ChaiAlex J KrotulskiMelissa FrisciaBrittany ChapmanEdward W BoyerBarry K LoganKavita M Babu

Published in: Clinical toxicology (Philadelphia, Pa.) (2017)

Heroin users presenting to the ED after heroin overdose requiring naloxone are unable to accurately identify the presence of nonpharmaceutical fentanyl in heroin. Additionally, cutting edge drug testing methodologies identified fentanyl exposures in 96.7% of our patients, as well as unexpected clandestine opioids (like acetylfentanyl and U-47700).

Keyphrases

end stage renal disease
emergency department
chronic kidney disease
newly diagnosed
ejection fraction
peritoneal dialysis
prognostic factors
chronic pain
air pollution
pain management
case report
patient reported outcomes
patient reported